Activated Clotting Time and Haemostatic Complications in Patients Receiving ECMO Support: A Systematic Review

<b>Background</b>: Extracorporeal membrane oxygenation (ECMO) requires systemic anticoagulation to prevent clotting, typically using unfractionated heparin (UFH). However, anticoagulation carries a bleeding risk, necessitating monitoring. Activated clotting time (ACT) is a commonly used monitoring t...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Daniel Schwaiger, Lukas Schausberger, Benedikt Treml, Dragana Jadzic, Nicole Innerhofer, Christoph Oberleitner, Zoran Bukumirić, Igor Spurnić, Sasa Rajsic
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2025-07-01
Schriftenreihe:	Journal of Cardiovascular Development and Disease
Schlagworte:	activated clotting time monitoring ACT anticoagulation extracorporeal membrane oxygenation ECMO
Online-Zugang:	https://www.mdpi.com/2308-3425/12/7/267
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!